HTAi :: HTAi Policy Forum Members

Abbott
Agency for Healthcare Research and Quality (AHRQ) (United States)
AstraZeneca
Australian Government Department of Health and Ageing: MSAC - Medical Services Advisory Committee
Australian Government Department of Health and Ageing: PBAC - Pharmaceutical Benefits Advisory Committee
Bayer Schering Pharma
BlueCross BlueShield Association (United States)
Canadian Agency for Drugs and Technologies in Health (CADTH)
Gencat (Generalitat de Catalunya – Catalonian Ministry of Health, Spain)
CVZ College voor zorgverzekeringen (Health Care Insurance Board, the Netherlands)
Eli Lilly and Company
GSK - GlaxoSmithKline
Institute for Clinical and Economic Review (ICER)
Johnson and Johnson
Kaiser Permanente
Medtronic
Merck
Merck Serono
MHRA (Medicines & Healthcare Products Regulatory Agency, United Kingdom)
NHS - NICE (National Institute for Health & Clinical Excellence, United Kingdom)
NOKC - (The Norwegian Knowledge Centre for the Health Services Norway)
Novartis
Pfizer
Roche (Hoffmann–La Roche AG, Switzerland)
Sanofi-Aventis
Stryker Corporation